BridgeMD
New treatment option for Pediatric Cancer
Official title Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
ClinicalTrials.gov ID: NCT06982066
What this study is testing
- What it's testing
- The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 25
You may be able to join if
- Adolescent and Young Adult Oncology Patients In order to be eligible to participate in this study, an individual must meet all of the following...
- Be aged 15-25 years old at time of enrollment.
- Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
- Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
- Radiotherapy: any radiotherapy to treat the cancer diagnosis.
You likely can't join if
- An individual who meets and of the following criteria will be excluded from participation in this study:
- Not currently on cancer-directed therapy.
- Unable to speak and read English.
- Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team) Pediatric Oncology...
See the full eligibility criteria
- Adolescent and Young Adult Oncology Patients In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Be aged 15-25 years old at time of enrollment.
- Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
- Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
- Radiotherapy: any radiotherapy to treat the cancer diagnosis.
- Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
- Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
- Be able to speak and read English
- Have permission to participate from a member of the patient's primary oncology team.
- Provision to sign and date the consent/assent form.
- Active study participation of primary oncology clinician
- Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute
- An individual who meets and of the following criteria will be excluded from participation in this study:
- Not currently on cancer-directed therapy.
- Unable to speak and read English.
- Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team) Pediatric Oncology Clinicians 1\. Be a pediatric oncology physician, clinical fellow, or...
The study team makes the final eligibility decision.
Where it's taking place
- Hartford, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hartford, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.